80 related articles for article (PubMed ID: 19957213)
1. Incidental detection of Sertoli-Leydig cell tumor by FDG PET/CT imaging in a patient with androgen insensitivity syndrome.
Ozülker T; Ozpaçaci T; Ozülker F; Ozekici U; Bilgiç R; Mert M
Ann Nucl Med; 2010 Jan; 24(1):35-9. PubMed ID: 19957213
[TBL] [Abstract][Full Text] [Related]
2. Complete androgen insensitivity syndrome with a Sertoli-Leydig cell tumor.
Fagouri H; Moussaoui DR; Kouach J; Babahabib A; Oukabli M; Ameur A; Albouzidi A; Dehayni M
J Pediatr Adolesc Gynecol; 2014 Oct; 27(5):e113-5. PubMed ID: 24333107
[TBL] [Abstract][Full Text] [Related]
3. FDG PET/CT Image of Seminoma in Androgen Insensitivity Syndrome.
Han EJ; O JH; Park G; Lee J
Clin Nucl Med; 2017 Aug; 42(8):e381-e382. PubMed ID: 28604478
[TBL] [Abstract][Full Text] [Related]
4. Primary amenorrhea in a young Polish woman with complete androgen insensitivity syndrome and Sertoli-Leydig cell tumor: identification of a new androgen receptor gene mutation and evidence of aromatase hyperactivity and apoptosis dysregulation within the tumor.
Jarzabek K; Philibert P; Koda M; Sulkowski S; Kotula-Balak M; Bilinska B; Kottler ML; Wolczynski S; Sultan C
Gynecol Endocrinol; 2007 Sep; 23(9):499-504. PubMed ID: 17852420
[TBL] [Abstract][Full Text] [Related]
5. PET imaging of Sertoli cell tumor in androgen insensitivity syndrome.
Nguyen BD
Clin Nucl Med; 2003 Sep; 28(9):743-5. PubMed ID: 12972996
[TBL] [Abstract][Full Text] [Related]
6. F-18 FDG PET/CT imaging of a Leydig cell tumor.
Lee G; Lee JH; Lee WA
Clin Nucl Med; 2010 Mar; 35(3):202-4. PubMed ID: 20173460
[TBL] [Abstract][Full Text] [Related]
7. Does recombinant human thyrotropin-stimulated positron emission tomography with [18F]fluoro-2-deoxy-D-glucose improve detection of recurrence of well-differentiated thyroid carcinoma in patients with low serum thyroglobulin?
Vera P; Kuhn-Lansoy C; Edet-Sanson A; Hapdey S; Modzelewski R; Hitzel A; d'Anjou J; Basuyau JP
Thyroid; 2010 Jan; 20(1):15-23. PubMed ID: 20017617
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive Oncologic Imaging in Infants and Preschool Children With Substantially Reduced Radiation Exposure Using Combined Simultaneous ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance Imaging: A Direct Comparison to ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography.
Gatidis S; Schmidt H; Gücke B; Bezrukov I; Seitz G; Ebinger M; Reimold M; Pfannenberg CA; Nikolaou K; Schwenzer NF; Schäfer JF
Invest Radiol; 2016 Jan; 51(1):7-14. PubMed ID: 26309185
[TBL] [Abstract][Full Text] [Related]
9. Combined [18F]Fluorodeoxyglucose positron emission tomography and computed tomography (FDG-PET/CT) for detection of recurrent, 131I-negative thyroid cancer.
Finkelstein SE; Grigsby PW; Siegel BA; Dehdashti F; Moley JF; Hall BL
Ann Surg Oncol; 2008 Jan; 15(1):286-92. PubMed ID: 17882493
[TBL] [Abstract][Full Text] [Related]
10. 18-fluorodeoxyglucose positron emission tomography enhances computed tomography diagnosis of malignant intraductal papillary mucinous neoplasms of the pancreas.
Sperti C; Bissoli S; Pasquali C; Frison L; Liessi G; Chierichetti F; Pedrazzoli S
Ann Surg; 2007 Dec; 246(6):932-7; discussion 937-9. PubMed ID: 18043094
[TBL] [Abstract][Full Text] [Related]
11. Incidental thyroid uptake on F-18 FDG PET/CT: correlation with ultrasonography and pathology.
Kang BJ; O JH; Baik JH; Jung SL; Park YH; Chung SK
Ann Nucl Med; 2009 Oct; 23(8):729-37. PubMed ID: 19768518
[TBL] [Abstract][Full Text] [Related]
12. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.
Kauhanen SP; Komar G; Seppänen MP; Dean KI; Minn HR; Kajander SA; Rinta-Kiikka I; Alanen K; Borra RJ; Puolakkainen PA; Nuutila P; Ovaska JT
Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of thyroid FDG uptake incidentally identified on FDG-PET/CT imaging.
Chen W; Parsons M; Torigian DA; Zhuang H; Alavi A
Nucl Med Commun; 2009 Mar; 30(3):240-4. PubMed ID: 19262287
[TBL] [Abstract][Full Text] [Related]
14. Placental-site trophoblastic tumor and fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography.
Çerçi SS; Erdemoglu E; Bozkurt KK; Yalçn Y; Erdemoglu E
Hell J Nucl Med; 2015; 18(3):264-7. PubMed ID: 26574698
[TBL] [Abstract][Full Text] [Related]
15. Missed causative tumors in diagnosing tumor-induced osteomalacia with (18)F-FDG PET/CT: a potential pitfall of standard-field imaging.
Kaneuchi Y; Hakozaki M; Yamada H; Hasegawa O; Tajino T; Konno S
Hell J Nucl Med; 2016; 19(1):46-8. PubMed ID: 26929940
[TBL] [Abstract][Full Text] [Related]
16. Clinical value of F18-fluorodeoxyglucose positron emission tomography-computed tomography in patients with non-small cell lung cancer after potentially curative surgery: experience with 241 patients.
Kanzaki R; Higashiyama M; Maeda J; Okami J; Hosoki T; Hasegawa Y; Takami M; Kodama K
Interact Cardiovasc Thorac Surg; 2010 Jun; 10(6):1009-14. PubMed ID: 20197344
[TBL] [Abstract][Full Text] [Related]
17. The case reported as bilateral Sertoli-Leydig cell tumors in a 61-year-old woman with uterine aplasia may instead represent complete androgen insensitivity syndrome.
Rutgers JK
Int J Gynecol Pathol; 2011 Jul; 30(4):395. PubMed ID: 21623193
[No Abstract] [Full Text] [Related]
18. Thyroid incidentalomas detected on 18F-fluorodeoxyglucose-positron emission tomography/computed tomography: Thyroid Imaging Reporting and Data System (TIRADS) in the diagnosis and management of patients.
Yoon JH; Cho A; Lee HS; Kim EK; Moon HJ; Kwak JY
Surgery; 2015 Nov; 158(5):1314-22. PubMed ID: 25958065
[TBL] [Abstract][Full Text] [Related]
19. A unique presentation of appendicitis: F-18 FDG PET/CT.
Koff SG; Sterbis JR; Davison JM; Montilla-Soler JL
Clin Nucl Med; 2006 Nov; 31(11):704-6. PubMed ID: 17053390
[TBL] [Abstract][Full Text] [Related]
20. Testicular Estrogen-Secreting Leydig Cell Tumor in 18F-FDG PET/CT: An Incidental Detection in a Patient Treated by Chemotherapy for Hodgkin Lymphoma.
Van Der Gucht A; Maged Z; Burruni R; Barras JL; Schaefer N
Clin Nucl Med; 2018 Jan; 43(1):41-43. PubMed ID: 29166332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
